The Provider Relief Fund: A Government Lesson in Unintended Consequences

The Provider Relief Fund (PRF) created a necessary cash infusion for healthcare providers during the pandemic. The pandemic required unprecedented government action to the tune of more than $19 billion distributed through the program. Now that the storm of Covid is behind us, the true story of PRF is around its success compared to mandated compliance requirements.

Key Points:

  • The after effects of reporting and compliance requirements in some instances left more questions than answers.
  • First time recipients have governmental compliance requirements and access to limited resources to get questions answered.
  • It is a priority to help health care clients manage their provider relief fund reporting challenges

Much-needed funding got into the hands of people who needed it. However, for many, this was their first experience dealing with a government-funded program. Understanding the requirements, from submission to reporting, may have been more complicated for even the most experienced—never mind the first-timer.

Weaver: Beyond The Numbers host Adam Jones, Weaver’s State Government Practice Leader, spoke with Weaver’s Health Care Services Partner-in-Charge, Anna Stevens, on the compliance challenges with PRF reporting. As Jones and Stevens see it, the problem is when the government follows a standard path and procedure for compliance and applies it to any situation; that can create confusion and problems.

“People that are receiving government funding or participating in federal programs on the regular have full departments that make sure their entities are complying with these requirements,” Stevens said. “But you have a one-physician practice now subject to these requirements; they certainly don’t have the staff to answer some of these requirements. What do you do?”

Anna Stevens, CPA, CHFP, has provided accounting services to healthcare organizations for over ten years. She has served clients in various for-profit and not-for-profit healthcare entities, including federally qualified health centers, behavioral health facilities, physician practices, ambulatory clinics, acute care hospitals, post-acute care facilities, and biotech companies.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…